Trastuzumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer

Clinical trial NCT00006089 · COMPLETED

Trial details

NCT number: NCT00006089
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Endometrial Adenocarcinoma ERBB2 Gene Amplification Recurrent Uterine Corpus Carcinoma Stage III Uterine Corpus Cancer AJCC v7 Stage IV Uterine Corpus Cancer AJCC v7

Start date: 2000-09-18
Primary completion: 2007-09-04
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.